Do you want to read an article? Please log in or register.
Brain and cord imaging features in neuromyelitis optica spectrum disorders
Further Publications NeurologyFurther Publications Psychiatry
RECOMMENDED
Related content
RECOMMENDED
Multiple Sclerosis
Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders
Lancet Neurol.
Ciccarelli O, Cohen JA, Reingold SC, Weinshenker BG; International Conference on Spinal Cord Involvement and Imaging in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders
doi: 10.1016/S1474-
RECOMMENDED
Multiple Sclerosis
Peripheral CD19+ B-cell counts and infusion intervals as a surrogate for long-term B-cell depleting therapy in multiple sclerosis and neuromyelitis optica/neuromyelitis optica spectrum disorders
J Neurol.
Ellrichmann G, Bolz J, Peschke M, Duscha A, Hellwig K, Lee DH, Linker RA, Gold R, Haghikia A
doi: 10.1007/s00415-018-9092-4.
Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response
J Neurol Neurosurg Psychiatry.
Stellmann JP, Krumbholz M, Friede T, Gahlen A, Borisow N, Fischer K, Hellwig K, Pache F, Ruprecht K, Havla J, Kümpfel T, Aktas O, Hartung HP, Ringelstein M, Geis C, Kleinschnitz C, Berthele A, Hemmer B, Angstwurm K, Young KL, Schuster S, Stangel M, Lauda F, Tumani H, Mayer C, Zeltner L, Ziemann U, Linker RA, Schwab M, Marziniak M, Then Bergh F, Hofstadt-van Oy U, Neuhaus O, Zettl U, Faiss J, Wildemann B, Paul F, Jarius S, Trebst C, Kleiter I; NEMOS (Neuromyelitis Optica Study Group)
doi: 10.1136/jnnp-2017-315603.
RECOMMENDED
Multiple Sclerosis
Safety and efficacy of tocilizumab versus azathioprine in highly relapsing neuromyelitis optica spectrum disorder (TANGO): an open-label, multicentre, randomised, phase 2 trial
★ 3
Recommended by
Prof. Dr Christian Kamm, Faculty Member
doi: 10.1016/S1474-4422(20)30070-3.
RECOMMENDED
Further Publications NeurologyFurther Publications Psychiatry
Eculizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder
N Engl J Med.
Pittock SJ, Berthele A, Fujihara K, Kim HJ, Levy M, Palace J, Nakashima I, Terzi M, Totolyan N, Viswanathan S, Wang KC, Pace A, Fujita KP, Armstrong R, Wingerchuk DM
doi: 10.1056/NEJMoa1900866.
RECOMMENDED
Further Publications NeurologyFurther Publications Psychiatry
Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial
★ 3
Recommended by
Prof. Dr Christian Kamm, Faculty Member
doi: 10.1016/S1474-4422(20)30078-8.
RECOMMENDED
Multiple Sclerosis
Trial of Satralizumab in Neuromyelitis Optica Spectrum Disorder
★ 1
Recommended by
Prof. Dr Claudio Gobbi, Faculty Member
★ 3
Recommended by
Prof. Dr Christian Kamm, Faculty Member
N Engl J Med.
Yamamura T, Kleiter I, Fujihara K, Palace J, Greenberg B, Zakrzewska-Pniewska B, Patti F, Tsai CP, Saiz A, Yamazaki H, Kawata Y, Wright P, De Seze J
doi: 10.1056/NEJMoa1901747.
EpilepsyAutism
Brain morphometry of preschool age children affected by autism spectrum disorder: correlation with clinical findings
Clin Anat.
Lucibello S, Verdolotti T, Giordano FM, Lapenta L, Infante A, Piludu F, Tartaglione T, Chieffo D, Colosimo C, Mercuri E, Battini R
doi: 10.1002/ca.23252.
Multiple Sclerosis
Quantitative spinal cord MRI in MOG-antibody disease, neuromyelitis optica and multiple sclerosis
Brain
Mariano R, Messina S, Roca-Fernandez A, Leite MI, Kong Y, Palace JA
doi: 10.1093/brain/awaa347